Recently, sodium nitroprusside (SNP), a potent nitric oxide (NO) donor and a clinically used antihypertensive, has been introduced as a penile self-injection medical therapy for erectile dysfunction. However, it is known that many antihypertensives impairs sexual competence; NO regulates sexual competence and NO is cytostatic and cytotoxic for human sperm. Thus, a possibility exists that SNP may impair male reproductive competence. Testing this aspect is the aim of this study. This was assessed in male rats (using three I.P. doses: 60, 30 or 20 g/kg) using noncompetitive copulation tests. The results show that the highest dose of SNP was toxic and caused rapid mortality of treated rats (within 30 min). The mid and low doses of SNP reversibly impaired several parameters of sexual competence in a dose-related fashion: sexual arousability, libido and sexual vigour. Some parameters of sexual behaviour remained unaltered: sexual motivation and intromission ratio, whilst one parameter was improved: sexual performance. In complete contrast, the ejaculatory competence and fertility remained unchanged. The SNP-induced impairments in sexual competence may be attributable to lowered testosterone levels and sedation mediated via its specific action and/or side effect. Further, this impairment of sexual function was not due to general toxicity, inhibition of penile sensitivity, penile erection or analgesic activity. It is concluded that SNP impairs male sexual competence, at least, in rats although it promotes penile erection.